- call +1-201-465-4211
- email sales@mrinsights.biz
Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria.
Scope of the Report:
The classification of bacterial vaginosis drug includes Rx and OTC, and the proportion of OTC in 2016 is about 72%.
Bacterial vaginosis drug is widely sold in hospital, pharmacy and other field. The most proportion of bacterial vaginosis drug is sold in pharmacy, and the revenue in 2016 is about 423 M USD.
USA region is the largest supplier of bacterial vaginosis drug, with a revenue market share nearly 32% in 2016. Europe is the second largest supplier of Bacterial Vaginosis Drug, enjoying revenue market share nearly 30% in 2016.
USA and Europe are the largest consumption places, with the consumption market share nearly 28% in 2016.
Market competition is intense. Bayer, Pfizer, Sanofi, Piramal, Abbott, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Bacterial Vaginosis Drug is expected to grow at a CAGR of roughly 3.1% over the next five years, will reach 970 million US$ in 2024, from 800 million US$ in 2019, according to a new study.
This report focuses on the Bacterial Vaginosis Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bayer
Pfizer
Sanofi
Piramal
Abbott
Galderma
Mission
Alkem
Xiuzheng
Teva
Perrigo
West-Ward
HPGC
Yunnan Baiyao
Starpharma
Novel
Edenvridge
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Rx
OTC
Market Segment by Applications, can be divided into
Hospital
Pharmacy
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bacterial Vaginosis Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bacterial Vaginosis Drug, with price, sales, revenue and global market share of Bacterial Vaginosis Drug in 2017 and 2018.
Chapter 3, the Bacterial Vaginosis Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bacterial Vaginosis Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Bacterial Vaginosis Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Bacterial Vaginosis Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Bacterial Vaginosis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Rx
1.2.2 OTC
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Pharmacy
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Bacterial Vaginosis Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Bacterial Vaginosis Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Bacterial Vaginosis Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Piramal
2.4.1 Business Overview
2.4.2 Bacterial Vaginosis Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Piramal Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Abbott
2.5.1 Business Overview
2.5.2 Bacterial Vaginosis Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Galderma
2.6.1 Business Overview
2.6.2 Bacterial Vaginosis Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Galderma Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Mission
2.7.1 Business Overview
2.7.2 Bacterial Vaginosis Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Mission Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Alkem
2.8.1 Business Overview
2.8.2 Bacterial Vaginosis Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Alkem Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Xiuzheng
2.9.1 Business Overview
2.9.2 Bacterial Vaginosis Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Xiuzheng Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Teva
2.10.1 Business Overview
2.10.2 Bacterial Vaginosis Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Teva Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Perrigo
2.11.1 Business Overview
2.11.2 Bacterial Vaginosis Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Perrigo Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 West-Ward
2.12.1 Business Overview
2.12.2 Bacterial Vaginosis Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 West-Ward Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 HPGC
2.13.1 Business Overview
2.13.2 Bacterial Vaginosis Drug Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 HPGC Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Yunnan Baiyao
2.14.1 Business Overview
2.14.2 Bacterial Vaginosis Drug Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Yunnan Baiyao Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Starpharma
2.15.1 Business Overview
2.15.2 Bacterial Vaginosis Drug Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Starpharma Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Novel
2.16.1 Business Overview
2.16.2 Bacterial Vaginosis Drug Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Novel Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Edenvridge
2.17.1 Business Overview
2.17.2 Bacterial Vaginosis Drug Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Edenvridge Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Bacterial Vaginosis Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Bacterial Vaginosis Drug Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Bacterial Vaginosis Drug Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Bacterial Vaginosis Drug Manufacturer Market Share in 2018
3.3.2 Top 6 Bacterial Vaginosis Drug Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Bacterial Vaginosis Drug Market Analysis by Regions
4.1 Global Bacterial Vaginosis Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Bacterial Vaginosis Drug Sales and Market Share by Regions (2014-2019)
4.1.2 Global Bacterial Vaginosis Drug Revenue and Market Share by Regions (2014-2019)
4.2 North America Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
4.3 Europe Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
4.5 South America Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
5 North America Bacterial Vaginosis Drug by Country
5.1 North America Bacterial Vaginosis Drug Sales, Revenue and Market Share by Country
5.1.1 North America Bacterial Vaginosis Drug Sales and Market Share by Country (2014-2019)
5.1.2 North America Bacterial Vaginosis Drug Revenue and Market Share by Country (2014-2019)
5.2 United States Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
5.3 Canada Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
5.4 Mexico Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
6 Europe Bacterial Vaginosis Drug by Country
6.1 Europe Bacterial Vaginosis Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Bacterial Vaginosis Drug Sales and Market Share by Country (2014-2019)
6.1.2 Europe Bacterial Vaginosis Drug Revenue and Market Share by Country (2014-2019)
6.2 Germany Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
6.3 UK Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
6.4 France Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
6.5 Russia Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
6.6 Italy Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Bacterial Vaginosis Drug by Country
7.1 Asia-Pacific Bacterial Vaginosis Drug Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Bacterial Vaginosis Drug Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Bacterial Vaginosis Drug Revenue and Market Share by Country (2014-2019)
7.2 China Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
7.3 Japan Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
7.4 Korea Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
7.5 India Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
8 South America Bacterial Vaginosis Drug by Country
8.1 South America Bacterial Vaginosis Drug Sales, Revenue and Market Share by Country
8.1.1 South America Bacterial Vaginosis Drug Sales and Market Share by Country (2014-2019)
8.1.2 South America Bacterial Vaginosis Drug Revenue and Market Share by Country (2014-2019)
8.2 Brazil Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
8.3 Argentina Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
8.4 Colombia Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Bacterial Vaginosis Drug by Countries
9.1 Middle East and Africa Bacterial Vaginosis Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Bacterial Vaginosis Drug Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Bacterial Vaginosis Drug Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
9.3 Turkey Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
9.4 Egypt Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
9.5 Nigeria Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
9.6 South Africa Bacterial Vaginosis Drug Sales and Growth Rate (2014-2019)
10 Global Bacterial Vaginosis Drug Market Segment by Type
10.1 Global Bacterial Vaginosis Drug Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Bacterial Vaginosis Drug Sales and Market Share by Type (2014-2019)
10.1.2 Global Bacterial Vaginosis Drug Revenue and Market Share by Type (2014-2019)
10.2 Rx Sales Growth and Price
10.2.1 Global Rx Sales Growth (2014-2019)
10.2.2 Global Rx Price (2014-2019)
10.3 OTC Sales Growth and Price
10.3.1 Global OTC Sales Growth (2014-2019)
10.3.2 Global OTC Price (2014-2019)
11 Global Bacterial Vaginosis Drug Market Segment by Application
11.1 Global Bacterial Vaginosis Drug Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Pharmacy Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Bacterial Vaginosis Drug Market Forecast (2019-2024)
12.1 Global Bacterial Vaginosis Drug Sales, Revenue and Growth Rate (2019-2024)
12.2 Bacterial Vaginosis Drug Market Forecast by Regions (2019-2024)
12.2.1 North America Bacterial Vaginosis Drug Market Forecast (2019-2024)
12.2.2 Europe Bacterial Vaginosis Drug Market Forecast (2019-2024)
12.2.3 Asia-Pacific Bacterial Vaginosis Drug Market Forecast (2019-2024)
12.2.4 South America Bacterial Vaginosis Drug Market Forecast (2019-2024)
12.2.5 Middle East and Africa Bacterial Vaginosis Drug Market Forecast (2019-2024)
12.3 Bacterial Vaginosis Drug Market Forecast by Type (2019-2024)
12.3.1 Global Bacterial Vaginosis Drug Sales Forecast by Type (2019-2024)
12.3.2 Global Bacterial Vaginosis Drug Market Share Forecast by Type (2019-2024)
12.4 Bacterial Vaginosis Drug Market Forecast by Application (2019-2024)
12.4.1 Global Bacterial Vaginosis Drug Sales Forecast by Application (2019-2024)
12.4.2 Global Bacterial Vaginosis Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Bacterial Vaginosis Drug Picture
Table Product Specifications of Bacterial Vaginosis Drug
Figure Global Sales Market Share of Bacterial Vaginosis Drug by Types in 20
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
